|
|
 |
N-(bis(4-methoxyphenyl)methyl)-6-oxo-2-(pyridazin-3-yl)-1,6-dihydropyrimidine-5-carboxamide |
1187990-87-9 |
 |
Nazartinib |
1508250-71-2 |
 |
Amiselimod (hydrochloride) |
942398-84-7 |
 |
1-(2,4-二氯苯基)-4-乙基-N-1-哌啶基-5-[5-[2-[4-(三氟甲基)苯基]乙炔基]-2-噻吩基]-1H-吡唑-3-甲酰胺 |
1253641-65-4 |
 |
CB1-IN-1 |
1429239-98-4 |
 |
GFT505 |
923978-27-2 |
 |
(R)-2,4-dihydroxy-3,3-dimethyl-N-(3-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-3-oxopropyl)butanamide |
1224691-12-6 |
 |
1H-Indole-3-carboxylic acid, 6-chloro-5-[4-(1-hydroxycyclobutyl)phenyl]- |
1467057-23-3 |
 |
2-(3,5-二羥基-2-辛烷基苯基)乙酸乙酯 |
321661-62-5 |
 |
N-(8-芐基-8-氮雜雙環(huán)[3.2.1]辛-3-基-外向)-2-甲基丙酰胺 |
376348-67-3 |
 |
H-beta-丙氨酰-7-氨基-4-甲基香豆素三氟乙酸鹽 |
201847-54-3 |
 |
T9281 |
1404117-65-2 |
 |
5-叔丁基-2-氟-4-[(4-甲基-5-氧代-1H-1,2,4-三唑-3-基)甲氧基]芐腈 |
2088365-27-7 |
 |
EP4 Receptor Antagonist 1 |
2287259-07-6 |
 |
6-溴-3-碘-9H-吡咯并[2,3-b:5,4-c]聯(lián)吡啶 |
1200130-87-5 |
|